Suzanne E. Fenton

Best Publications

• EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals

  A. C. Gore;V. A. Chappell;S. E. Fenton;J. A. Flaws

  2372
  Citations

• Per- and Polyfluoroalkyl Substance Toxicity and Human Health Review: Current State of Knowledge and Strategies for Informing Future Research.

  Suzanne E. Fenton;Alan Ducatman;Alan Boobis;Jamie C. DeWitt

  2016
  Citations

• Executive Summary to EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals

  A. C. Gore;V. A. Chappell;S. E. Fenton;J. A. Flaws

  717
  Citations

• Cancer and developmental exposure to endocrine disruptors.

  Linda S Birnbaum;Suzanne E Fenton

  620
  Citations

• Endocrine-Disrupting Compounds and Mammary Gland Development: Early Exposure and Later Life Consequences

  Unknown

  370
  Citations

• Phenotypic dichotomy following developmental exposure to perfluorooctanoic acid (PFOA) in female CD-1 mice: Low doses induce elevated serum leptin and insulin, and overweight in mid-life.

  Unknown

  346
  Citations

• Endocrine disrupting properties of perfluorooctanoic acid

  Unknown

  342
  Citations

• Per- and poly-fluoroalkyl substances (PFAS) and female reproductive outcomes: PFAS elimination, endocrine-mediated effects, and disease.

  Unknown

  286
  Citations

• Concentrations of phthalate metabolites in milk, urine, saliva, and Serum of lactating North Carolina women.

  Erin P. Hines;Antonia M. Calafat;Manori J. Silva;Pauline Mendola

  276
  Citations

• Environmental exposures and mammary gland development: state of the science, public health implications, and research recommendations.

  Ruthann A. Rudel;Suzanne E. Fenton;Janet M. Ackerman;Susan Y. Euling

  253
  Citations

• Gestational PFOA exposure of mice is associated with altered mammary gland development in dams and female offspring.

  Sally S. White;Antonia M. Calafat;Zsuzsanna Kuklenyik;LaTonya Villanueva;LaTonya Villanueva

  250
  Citations

• Evaluation of Maternal, Embryo, and Placental Effects in CD-1 Mice following Gestational Exposure to Perfluorooctanoic Acid (PFOA) or Hexafluoropropylene Oxide Dimer Acid (HFPO-DA or GenX).

  Bevin E. Blake;Bevin E. Blake;Harlie A. Cope;Samantha M. Hall;Robert D. Keys

  247
  Citations

• Developmental Exposure to a Commercial PBDE Mixture, DE-71: Neurobehavioral, Hormonal, and Reproductive Effects

  Prasada Rao S. Kodavanti;Cary G. Coburn;Virginia C. Moser;Robert C. MacPhail

  228
  Citations

• Developmental toxicity of perfluorooctanoic acid in the CD-1 mouse after cross-foster and restricted gestational exposures.

  Cynthia J. Wolf;Suzanne E. Fenton;Judith E. Schmid;Antonia M. Calafat

  214
  Citations

• Associations between longitudinal serum perfluoroalkyl substance (PFAS) levels and measures of thyroid hormone, kidney function, and body mass index in the Fernald Community Cohort.

  Unknown

  206
  Citations

• Endocrine Disruptors and the Breast: Early Life Effects and Later Life Disease

  Unknown

  201
  Citations

• Persistent Abnormalities in the Rat Mammary Gland following Gestational and Lactational Exposure to 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD)

  Suzanne E. Fenton;Jonathan T. Hamm;Linda S. Birnbaum;Geri L. Youngblood

  200
  Citations

• Exposure to diethylstilbestrol during sensitive life stages: A legacy of heritable health effects

  Unknown

  193
  Citations

• Concentrations of environmental phenols and parabens in milk, urine and serum of lactating North Carolina women.

  Erin P. Hines;Pauline Mendola;Ondine S. von Ehrenstein;Xiaoyun Ye

  187
  Citations

• Brominated Flame Retardants

  Unknown

  167
  Citations